Omega Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FLAGSHIP PIONEERING INC. | 02/14/2025 | 29.23 M | $21.79 M | 0.00% | 52.99% |
FMR LLC | 02/13/2025 | 5.92 M | $4.42 M | -2.26% | 10.74% |
HARBOURVEST PARTNERS LLC | 02/14/2025 | 3.51 M | $2.62 M | 0.00% | 6.37% |
STATE OF WISCONSIN INVESTMENT BOARD | 02/14/2025 | 1.86 M | $1.38 M | 0.00% | 3.37% |
SIREN, L.L.C. | 02/14/2025 | 1.32 M | $986,824 | 0.00% | 2.40% |
VANGUARD GROUP INC | 02/11/2025 | 1.10 M | $818,441 | -1.58% | 1.99% |
BLUE OWL CAPITAL HOLDINGS LP | 02/14/2025 | 1.06 M | $787,266 | 0.00% | 1.91% |
683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 600,000 | $447,360 | 0.00% | 1.09% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 520,898 | $388,382 | -2.75% | 0.94% |
72 INVESTMENT HOLDINGS, LLC | 02/14/2025 | 352,941 | $263,153 | 0.00% | 0.64% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 272,051 | $202,841 | 0.15% | 0.49% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 230,833 | $172,158 | 0.00% | 0.42% |
STATE OF MICHIGAN RETIREMENT SYSTEM | 02/06/2025 | 224,117 | $167,102 | -28.65% | 0.41% |
UBS GROUP AG | 02/14/2025 | 163,904 | $122,273 | 5,378.07% | 0.30% |
WOODLINE PARTNERS LP | 02/14/2025 | 122,191 | $91,106 | 100.00% | 0.22% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 116,009 | $86,496 | 0.00% | 0.21% |
LONG CORRIDOR ASSET MANAGEMENT LTD | 02/12/2025 | 85,000 | $63,376 | 0.00% | 0.15% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 64,000 | $47,718 | -46.22% | 0.12% |
RBF CAPITAL, LLC | 02/14/2025 | 63,857 | $47,612 | 0.00% | 0.12% |
GREEN ALPHA ADVISORS, LLC | 01/13/2025 | 47,647 | $35,526 | -23.84% | 0.09% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 31,617 | $23,574 | 0.00% | 0.06% |
RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 30,091 | $22,436 | 100.00% | 0.05% |
PATHSTONE HOLDINGS, LLC | 02/14/2025 | 26,789 | $19,974 | -34.32% | 0.05% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 21,744 | $16,212 | -73.19% | 0.04% |
CERTUITY, LLC | 01/29/2025 | 20,000 | $14,912 | 33.33% | 0.04% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 18,440 | $13,749 | -21.33% | 0.03% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 17,820 | $13,287 | -96.25% | 0.03% |
MURPHY POHLAD ASSET MANAGEMENT LLC | 01/23/2025 | 16,500 | $12,302 | 0.00% | 0.03% |
EQIS CAPITAL MANAGEMENT, INC. | 02/13/2025 | 14,785 | $11,023 | 17.92% | 0.03% |
COLONY GROUP, LLC | 02/14/2025 | 14,000 | $10,439 | 100.00% | 0.03% |
BARCLAYS PLC | 02/13/2025 | 13,278 | $10,000 | 0.00% | 0.02% |
TWO SIGMA SECURITIES, LLC | 02/14/2025 | 12,053 | $8,987 | 100.00% | 0.02% |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/06/2025 | 5,000 | $3,728 | 0.00% | 0.01% |
CITIGROUP INC | 02/12/2025 | 2,720 | $2,028 | 8,674.19% | 0.00% |
HM PAYSON & CO | 02/07/2025 | 2,500 | $1,864 | 100.00% | 0.00% |
PRINCIPAL SECURITIES, INC. | 01/30/2025 | 1,370 | $1,021 | 0.00% | 0.00% |
ALLSQUARE WEALTH MANAGEMENT LLC | 02/11/2025 | 1,000 | $746 | 0.00% | 0.00% |
POINT72 (DIFC) LTD | 02/14/2025 | 954 | $711 | 0.00% | 0.00% |
GROUP ONE TRADING, L.P. | 02/14/2025 | 900 | $671 | -73.97% | 0.00% |
SANDY SPRING BANK | 02/11/2025 | 750 | $560 | 0.00% | 0.00% |
JPMORGAN CHASE & CO | 02/12/2025 | 503 | $375 | 0.00% | 0.00% |
02/06/2025 | 415 | $309 | 100.00% | 0.00% | |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 292 | $218 | -93.61% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 235 | $175 | 100.00% | 0.00% |
02/26/2025 | 24 | $18 | 100.00% | 0.00% | |
HUNTINGTON NATIONAL BANK | 02/12/2025 | 1 | $1 | 0.00% | 0.00% |
HARBOUR INVESTMENTS, INC. | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
PLATINUM INVESTMENT MANAGEMENT LTD | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
SIMPLEX TRADING, LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
Omega Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 60 institutional investors and hedge funds held shares of Omega Therapeutics, Inc.. The most heavily invested institutionals were:
Flagship Pioneering Inc.: 29.23 M
FMR LLC: 5.92 M
HARBOURVEST PARTNERS LLC: 3.51 M
STATE OF WISCONSIN INVESTMENT BOARD: 1.86 M
Siren, L.L.C.: 1.32 M
VANGUARD GROUP INC: 1.1 M
85.72% of Omega Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 48.71 M shares in the last 24 months. This purchase volume represents approximately $6.82 M in transactions.